Skip to main content

Table 2 Local control and survival rates after stereotactic body radiation therapy

From: Lung stereotactic body radiation therapy for elderly patients aged ≥ 80 years with pathologically proven early-stage non-small cell lung cancer: a retrospective cohort study

Parameter

1-year

3-year

5-year

Local control (%)

98.4

90.1

87.4

Cancer-specific survival (%)

98.4

93.7

83.5

Progression-free survival (%)

81.0

58.9

38.2

Overall survival (%)

88.9

68.3

47.5